ADVB Statistiques clés
Haut
18.73
Ouverture
8.32
Volume
23.55M
Bas
8.08
Clôture précédente
7.08
Valeur négociée
312.10M
Plus haut 52 sem.
18.73
Vol. relatif
5.794
Amplitude (%)
150.42%
Plus bas 52 sem.
3.61
Taux de rotation
1425.97%
Cap. Marché
11.69M
PER (TTM)
44.47
PER (Annuel)
--
P/B
1.27
P/S
--
Bénéfice par action (BPA)
0.159
Dividende (TTM)
0
Rendement du dividende
0.00%
Actions en circulation
1.65M
Devise
USD
ADVB Performance du Prix
7 jour
30 jour
90 jour
180 jour
Depuis le début de l’année
1 An
ADVB Répartition des flux monétaires
ADVB Volume quotidien des ventes à découvert
ADVB Historique du short interest
ADVB Aperçu de l’action
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 12.41. Based on this price, the company has a market capitalization of $11.69M, with a P/E ratio of 44.47.
On 2026-07-22, ADVB traded between 8.08 and 18.73. Today’s stock price is 53.59% above the daily low and 33.74% below the daily high, placing ADVB près du milieu de its most recent trading range.
Trading volume currently stands at 23.55M, compared with an average daily volume of 4.06M. This suggests that trading activity is nettement supérieur à son niveau habituel than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 18.73. At today’s price, ADVB is 243.77% above its 52-week low and 33.74% below its 52-week high.
ADVB Actualités liées
À propos ADVB
Nom l'entreprise
Advanced Biomed Inc.
Secteur
Health Technology
Industrie
Biotechnology
Exchanges
Nasdaq
Nombre d’employés
31
Taille du lot
100
Site officiel
Devise
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Related Stocks
ADVB FAQ
© 2026 CoinGlass, all rights reserved
